BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Mallinckrodt
McKinsey
Baxter
Dow
Fish and Richardson
Accenture
US Department of Justice
Cantor Fitzgerald

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,873,360

« Back to Dashboard

Summary for Patent: 5,873,360
Title: Inhalation device
Abstract:An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.
Inventor(s): Davies; Michael Birsha (Ware, GB2), Hearne; David John (Luton, GB2), Rand; Paul Kenneth (Letchworth, GB2), Walker; Richard Ian (Ware, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:08/467,469
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 5,873,360

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxo Grp Ltd ADVAIR DISKUS 100/50 fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 021077-001 Aug 24, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxo Grp Ltd ADVAIR DISKUS 250/50 fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 021077-002 Aug 24, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxo Grp Ltd ADVAIR DISKUS 500/50 fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 021077-003 Aug 24, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxo Grp Ltd FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833-002 Sep 29, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxo Grp Ltd FLOVENT DISKUS 50 fluticasone propionate POWDER;INHALATION 020833-001 Sep 29, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline SEREVENT salmeterol xinafoate POWDER;INHALATION 020692-001 Sep 19, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,873,360

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom90 04781Mar 02, 1990

Non-Orange Book US Patents Family Members for Patent 5,873,360

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,032,666 Inhalation device ➤ Subscribe
2,006,107,948 ➤ Subscribe
6,792,945 Inhalation device ➤ Subscribe
2,007,107,724 ➤ Subscribe
6,378,519 Inhalation device ➤ Subscribe
5,860,419 Inhalation device ➤ Subscribe
5,590,645 Inhalation device ➤ Subscribe
7,389,775 Inhalation device ➤ Subscribe
6,536,427 Inhalation device ➤ Subscribe
7,225,808 Inhalation device ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,873,360

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 310 ➤ Subscribe
African Regional IP Organization (ARIPO) 9100321 ➤ Subscribe
Austria 401007 ➤ Subscribe
Austria A43791 ➤ Subscribe
Australia 5926794 ➤ Subscribe
Australia 645056 ➤ Subscribe
Australia 675825 ➤ Subscribe
Australia 7202591 ➤ Subscribe
Belgium 1003798 ➤ Subscribe
Brazil 9100843 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
Daiichi Sankyo
Fish and Richardson
Colorcon
AstraZeneca
Dow
Boehringer Ingelheim
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot